Botulinum-A Toxin Detrusor and Sphincter Injection in Treatment of Overactive Bladder Syndrome: Objective Outcome and Patient Satisfaction
- 1 December 2005
- journal article
- clinical trial
- Published by Elsevier BV in European Urology
- Vol. 48 (6), 984-990
- https://doi.org/10.1016/j.eururo.2005.06.021
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Darifenacin, an M3 Selective Receptor Antagonist, is an Effective and Well-Tolerated Once-Daily Treatment for Overactive BladderEuropean Urology, 2004
- Update on overactive bladder: Pharmacologic approaches on the horizonCurrent Urology Reports, 2003
- Prevalence and burden of overactive bladder in the United StatesWorld Journal of Urology, 2003
- Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic reviewBMJ, 2003
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- Efficacy, tolerability and safety profile of propiverine in the treatment of the overactive bladder (non-neurogenic and neurogenic)World Journal of Urology, 2001
- How widespread are the symptoms of an overactive bladder and how are they managed? A population‐based prevalence studyBJU International, 2001
- Treatment of overactive bladder: long-term tolerability and efficacy of tolterodine.World Journal of Urology, 2001
- OxybutyninDrugs & Aging, 1995
- Structural Basis of Geriatric Voiding Dysfunction. III. Detrusor OveractivityJournal of Urology, 1993